Literature DB >> 31742649

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.

C Elise Kleyn1, Peter S Talbot, Nehal N Mehta, Francesca Sampogna, Chris Bundy, Darren M Ashcroft, Alexa B Kimball, Peter C M van de Kerkhof, Christopher E M Griffiths, Fernando Valenzuela, Joelle M van der Walt, Tsion Aberra, Lluís Puig.   

Abstract

Psoriasis is a systemic, relapsing, inflammatory disease associated with serious comorbidities including mood problems and/or unhealthy lifestyle behaviours. Cutaneous and systemic abnormalities in innate and acquired immunity play a role in its pathogenesis. The exact pathogenetic mechanism remains elusive. Evidence is accumulating that TNF-alpha, IL-17 and IL-23 signalling are highly relevant as targeting these pathways reduces disease activity. Evidence suggests a strong link between psoriasis and depression in adults. The International Psoriasis Council (IPC) held a roundtable event, "Psoriasis and Mental Health", in Barcelona, Spain which focused on the presence of depression and suicidality, plus the role of neuroinflammation in psoriasis, sleep disruption and the impact of depression on cardiovascular disease outcomes. We summarize here the expert presentations to provide additional insight into the understanding of psychiatric comorbidities of psoriasis and of the impact of chronic, systemic inflammation on neuro- and cardiovascular outcomes. the associations between psoriasis and other psychiatric comorbidities are still controversial and warrant further attention.

Entities:  

Keywords:  cardiovascular mental health; depression; neuroinflammation; psoriasis; sleep

Mesh:

Year:  2020        PMID: 31742649      PMCID: PMC9128964          DOI: 10.2340/00015555-3375

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  83 in total

Review 1.  Psoriasis and suicidality: A systematic review and meta-analysis.

Authors:  Sanminder Singh; Catherine Taylor; Heather Kornmehl; April W Armstrong
Journal:  J Am Acad Dermatol       Date:  2017-09       Impact factor: 11.527

Review 2.  Changes in alexithymia following psychological intervention: a review.

Authors:  Kristjana Cameron; John Ogrodniczuk; George Hadjipavlou
Journal:  Harv Rev Psychiatry       Date:  2014 May-Jun       Impact factor: 3.732

3.  The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.

Authors:  Jonas Hannestad; Nicole DellaGioia; Jean-Dominique Gallezot; Keunpoong Lim; Nabeel Nabulsi; Irina Esterlis; Brian Pittman; Jae-Yun Lee; Kevin C O'Connor; Daniel Pelletier; Richard E Carson
Journal:  Brain Behav Immun       Date:  2013-07-09       Impact factor: 7.217

Review 4.  Social interactions, emotion and sleep: A systematic review and research agenda.

Authors:  Louise Beattie; Simon D Kyle; Colin A Espie; Stephany M Biello
Journal:  Sleep Med Rev       Date:  2014-12-27       Impact factor: 11.609

5.  Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.

Authors:  F Sampogna; L Puig; P Spuls; G Girolomoni; M A Radtke; B Kirby; M Brunori; P Bergmans; P Smirnov; J Rundle; F Lavie; C Paul
Journal:  Br J Dermatol       Date:  2017-04-10       Impact factor: 9.302

6.  Prevalence and sociodemographic correlates of alexithymia in a population sample of young adults.

Authors:  P Kokkonen; J T Karvonen; J Veijola; K Läksy; J Jokelainen; M R Järvelin; M Joukamaa
Journal:  Compr Psychiatry       Date:  2001 Nov-Dec       Impact factor: 3.735

Review 7.  Psoriasis and the metabolic syndrome.

Authors:  Paolo Gisondi; Anna Chiara Fostini; Irene Fossà; Giampiero Girolomoni; Giovanni Targher
Journal:  Clin Dermatol       Date:  2017-09-08       Impact factor: 3.541

Review 8.  Inflammation and depression.

Authors:  Patricia A Zunszain; Nilay Hepgul; Carmine M Pariante
Journal:  Curr Top Behav Neurosci       Date:  2013

9.  Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.

Authors:  R B Warren; A Marsden; B Tomenson; K J Mason; M M Soliman; A D Burden; N J Reynolds; D Stocken; R Emsley; C E M Griffiths; C Smith
Journal:  Br J Dermatol       Date:  2018-08-28       Impact factor: 9.302

Review 10.  Exploring the Physiological Link between Psoriasis and Mood Disorders.

Authors:  Cody J Connor; Vincent Liu; Jess G Fiedorowicz
Journal:  Dermatol Res Pract       Date:  2015-10-15
View more
  4 in total

1.  Common Fundamentals of Psoriasis and Depression.

Authors:  Stefanie Hölsken; Frederik Krefting; Manfred Schedlowski; Wiebke Sondermann
Journal:  Acta Derm Venereol       Date:  2021-11-30       Impact factor: 3.875

2.  Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice.

Authors:  Hiroyo Shinno-Hashimoto; Yaeko Hashimoto; Yan Wei; Lijia Chang; Yuko Fujita; Tamaki Ishima; Hiroyuki Matsue; Kenji Hashimoto
Journal:  Sci Rep       Date:  2021-05-28       Impact factor: 4.379

3.  Internalized Stigma and Psychiatric Morbidity among Patients with Psoriasis: A Study from North India.

Authors:  Sandeep Grover; Aseem Mehra; Sunil Dogra; Nandita Hazari; Nidhi Malhora; Tarun Narang; Swapanjeet Sahoo; Sunil Sharma; Sanjeev Handa; Ajit Avasthi
Journal:  Indian Dermatol Online J       Date:  2020-09-28

4.  Affective temperament, depressive symptoms and interleukins in patients with psoriasis.

Authors:  Luiza Marek-Józefowicz; Marcin Jaracz; Alina Borkowska
Journal:  Postepy Dermatol Alergol       Date:  2021-03-10       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.